Description
What is EBIXA 10MG TABS 28`S?
EBIXA 10MG tablets effectively treat moderate to severe Alzheimer’s disease. These tablets contain memantine, a medication that helps manage symptoms of cognitive decline. By acting on the central nervous system, EBIXA supports memory function, awareness, and the ability to perform daily activities.
Key Benefits of EBIXA 10MG
-
Improves cognitive function
-
Enhances memory and communication
-
Helps maintain daily independence
-
Regulates glutamate activity in the brain
-
Improves quality of life for both patients and caregivers
Patients using EBIXA 10MG often report better daily functioning and reduced confusion or forgetfulness.
How Does EBIXA 10MG Work?
Memantine, the active ingredient in EBIXA 10MG TABS 28`S, works by controlling the activity of NMDA receptors in the brain. These receptors are linked to glutamate, a key neurotransmitter for memory and learning. When glutamate levels are too high, they overstimulate brain cells, causing damage. EBIXA 10MG reduces this overstimulation and helps protect neurons from further harm.
Usage and Dosage
-
Take as prescribed by your doctor
-
Swallow tablets whole with water
-
Take at the same time each day
-
Do not crush or chew
-
Dosage may be adjusted gradually
Following your doctor’s instructions carefully ensures the best results.
Possible Side Effects
-
Dizziness
-
Headache
-
Confusion
-
Constipation
Most side effects are mild and temporary. Contact your doctor if they persist or worsen.
Important Precautions
Before taking EBIXA 10MG:
-
Inform your doctor of kidney problems or seizures
-
Mention any medications or supplements
-
Keep regular checkups to monitor progress
Conclusion
EBIXA 10MG TABS 28`S is a proven treatment for moderate to severe Alzheimer’s disease. Its active ingredient, memantine, helps regulate brain activity, protect nerve cells, and slow cognitive decline. With regular use and medical guidance, EBIXA 10MG improves the patient’s quality of life and eases caregiving. Always consult your doctor before starting this treatment.
